Europe to accelerate trials of gene-engineered COVID-19 vaccines

0
2

BRUSSELS: European officials aim to speed up trials for COVID-19 vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like AstraZeneca and Johnson & Johnson. The European Commission is expected to put forward the plans as early as next week.

NO COMMENTS